Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Withdrawal Effects of Oxycodone/Naltrexone in Methadone-Maintained Subjects
NCT02391571Phase 3Completed
- Sponsor
- Elite Pharmaceuticals, Inc.
- Start
- Feb 2015
- Primary completion
- Mar 2015
- Modality
- Drug Delivery Systems, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxycodone + naltrexone in pain, sponsored by Elite Pharmaceuticals, Inc.. Started Feb 2015; status: completed.
02
Drugs
oxycodone + naltrexone
03
Conditions
pain
Beyond the preview
Go deeper on NCT02391571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02391571.